(Q38450757)

3 September 2017

P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder (English)

1 reference

transitional cell carcinoma

3 September 2017

1 reference

1

Bartosz Dybowski

1 reference

3 September 2017

2

Jolanta Kupryjańczyk

1 reference

3 September 2017

Alina Rembiszewska

3

1 reference

PubMed ID

14517702

3 September 2017

Roman Pykało

series ordinal

4

1 reference

PubMed ID

14517702

3 September 2017

Andrzej Borkowski

series ordinal

5

1 reference

3 September 2017

27 September 2003

1 reference

3 September 2017

1 reference

3 September 2017

31

1 reference

3 September 2017

397-401

1 reference

3 September 2017

6

1 reference

Superficial bladder cancer: progression and recurrence

3 September 2017

1 reference

12 December 2020

Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

1 reference

12 December 2020

Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification

1 reference

12 December 2020

p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors

1 reference

12 December 2020

Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer

1 reference

12 December 2020

Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.

1 reference

12 December 2020

Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder

1 reference

12 December 2020

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

1 reference

12 December 2020

MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors

1 reference

12 December 2020

Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival

1 reference

12 December 2020

Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort

1 reference

12 December 2020

p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?

1 reference

12 December 2020

Factors affecting recurrence and progression in superficial bladder tumours.

1 reference

12 December 2020

Prognostic significance of Ki-67 reactivity in soft tissue sarcomas

1 reference

12 December 2020

Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer

1 reference

12 December 2020

Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome

1 reference

12 December 2020

Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma

1 reference

12 December 2020

Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy

1 reference

12 December 2020

The impact of primary stage on survival in patients with lymph node positive bladder cancer.

1 reference

12 December 2020

The Ki-67 protein: from the known and the unknown

1 reference

12 December 2020

Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy

1 reference

12 December 2020

The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma

1 reference

12 December 2020

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group

1 reference

12 December 2020

Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors

1 reference

12 December 2020

Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis

1 reference

12 December 2020

Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

The expression of Ki-67, MCM3, and p27 defines distinct subsets of proliferating, resting, and differentiated cells.

1 reference

12 December 2020

MIB-1 labelling index is an independent prognostic marker in primary breast cancer

1 reference

12 December 2020

The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder

1 reference

12 December 2020

The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas

1 reference

12 December 2020

Low p27 expression predicts poor disease-free survival in patients with prostate cancer

1 reference

12 December 2020

Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer

1 reference

12 December 2020

Prospective Evaluation of Ki–67 Labeling in Predicting the Recurrence and Progression of Superficial Bladder Transitional Cell Carcinoma

1 reference

12 December 2020

p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers

1 reference

12 December 2020

Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers

1 reference

12 December 2020

10.1007/S00240-003-0356-8

Identifiers

DOI

1 reference

3 September 2017

1 reference

PubMed ID

14517702